One Stop Solution For In-Depth Market Research Reports

詳細な市場調査レポートのワンストップソリューション

Home    >    HEALTHCARE AND PHARMACEUTICALS   >   Human Liver Models Market

[ 英語タイトル ] Human Liver Models Market by Drug Discovery Platform (Non-alcoholic Fatty Liver Organoids, Liver-on-a-chip, 2D Models, Animal Models, 3D Bioprinting), and Region (North America, Europe, Asia Pacific, Rest of the World) - Global Forecast to 2022


Product Code : MNMHC00109702
Survey : MarketsandMarkets
Publish On : May, 2021
Category : Healthcare and Pharmaceuticals
Study Area : Global
Report format : PDF
Sales price option (consumption tax not included)
Single User USD5650 / Question Form
5 User USD6650 / Question Form
Enterprise User USD10000 / Question Form

[Report Description]

The human liver models market is projected to grow at a CAGR of 13.6% during the forecast period”
The global human liver models market is expected to reach USD 2.56 billion by 2022 from USD 1.35 billion in 2017, at a CAGR of 13.6%. Growing focus on developing alternatives for animal testing models, significant increase in research funding and venture capital investments for the development of liver models, growing initiatives to increase awareness about liver organoids, increasing research activities on liver organoids, increasing prevalence of non-alcoholic fatty liver disease, and growing need for the early detection of drug toxicity to minimize financial losses due to late-stage drug failure are expected to drive the growth of the human liver models market. However, issues related to the incorporation of organoids into existing workflows are expected to restrain the growth of this market to a certain extent.

“By type, the liver-on-a-chip segment is expected to grow at the highest rate during the forecast period”
Based on type, the market is segmented into liver organoids, liver-on-a-chip, 2D models, animal models, and 3D bioprinting. The liver-on-a-chip segment is expected to grow at the highest CAGR during the forecast period. This can be attributed to the simplicity of this model and the ability of on-chip hepatic tissues to maintain metabolic activity and phenotype similar to that of the in vivo environment. Moreover, the majority of the key players, research institutes, and government and non-government organizations are raising funds for the development of innovative liver-based models. In addition, key players operating in this market are entering into partnerships and collaborations with pharmaceutical companies to strengthen their market position. This strategy is enabling market players to evaluate the performance of their livers-on-a-chip offerings in drug development and other pharmaceutical research processes. Such funding initiatives from the government and private investors are expected to provide an impetus to market growth.

“The North American human liver models market is expected to grow at the highest CAGR during the forecast period”
North America is expected to witness the highest growth during 2017 to 2022, owing to well-established pharmaceutical and biotechnology industry and increasing government spending. Furthermore, growing initiatives to increase awareness about organoids and growing incidence of NAFLD is expected to boost the market.

Break of primary participants was as mentioned below:
• By Company Type – Tier 1–50%, Tier 2–30% and Tier 3–20%
• By Designation – C-level–30%, Director Level–48%, Others–22%
• By Region – North America–48%, Europe–20%, Asia Pacific–25%, Row–7%

The key players in the global human liver models market are Emulate (US), Ascendance Bio (US), HμREL (US), CN Bio (UK), Organovo (US), and Cyfuse Biomedical (Japan).


Research Coverage:
The report analyzes the human liver models market and aims at estimating the market size and future growth potential of this market based on various segments such as type and region. It provides detailed information regarding the major factors influencing the growth of this market and the regulatory analysis impacting market dynamics.
Reasons to Buy the Report
The report can help established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them garner a greater share. Firms purchasing the report could use one or any combination of the below mentioned three strategies.

This report provides insights into the following pointers:
• Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and product launches in the human liver models market
• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various human liver models across regions
• Market Diversification: Exhaustive information about products, untapped regions, recent developments, and investments in the human liver models market

TABLE OF CONTENTS

1 MARKET OVERVIEW FOR HUMAN LIVER MODELS 8
1.1 INTRODUCTION 8
1.2 MARKET DYNAMICS 8
1.2.1 DRIVERS 9
1.2.1.1 Growing focus on developing alternatives for animal testing models 9
1.2.1.2 Significant increase in research funding and venture capital investments for the development of liver organoids 9
1.2.1.3 Growing initiatives to increase awareness about liver organoids 10
1.2.1.4 Increasing research activities on liver organoids 11
1.2.1.5 Increasing prevalence of non-alcoholic fatty liver disease 12
1.2.1.6 Growing need for the early detection of drug toxicity to minimize financial losses due to late-stage drug failure 13
1.2.2 RESTRAINTS 13
1.2.2.1 Issues related to the incorporation of organoids into existing workflows 13
1.2.3 OPPORTUNITIES 14
1.2.3.1 Increasing focus on drug discovery activities 14
1.2.3.2 Rising demand for liver transplantation 14
1.2.3.3 Growing healthcare market in the Asia Pacific and Latin America 15
1.2.4 CHALLENGES 16
1.2.4.1 Dearth of skilled professionals 16
2 INDUSTRY SPEAKS – IN VITRO LIVER MODELS 17
3 HUMAN LIVER MODELS MARKET, BY DRUG DISCOVERY PLATFORM 20
3.1 INTRODUCTION 20
3.1.1 LIVER ORGANOIDS 21
3.1.2 LIVER-ON-A-CHIP 22
3.1.3 2D MODELS 23
3.1.4 ANIMAL MODELS 23
3.1.5 3D BIOPRINTING 25
4 GEOGRAPHIC ASSESSMENT 27
4.1 INTRODUCTION 27
4.2 NORTH AMERICA 27
4.2.1 US 27
4.2.2 CANADA 28
4.3 EUROPE 29
4.4 ASIA PACIFIC 30
4.4.1 CHINA 31
4.4.2 JAPAN 33
4.4.3 INDIA 34
4.4.4 REST OF ASIA PACIFIC 35
4.5 REST OF THE WORLD 35
4.6 AUTHOR DETAILS 37

渋谷データカウント

渋谷データカウントは、最も信頼性が高く最新の調査分析レポートを確実に提供する経験豊富な調査専門家のグローバルチームが提供する、さまざまな業界のさまざまな市場調査レポートを提供する再販代理店です。

Recommended reports

+